USTEKINUMAB IS MORE EFFECTIVE THAN AZATHIOPRINE TO PREVENT ENDOSCOPIC POSTOPERATIVE RECURRENCE IN CROHN´S DISEASE

Anthony Buisson  ¹     Stephane NANCEY  ²     Luc Manlay  ²     David T. Rubin  ³     Xavier Hebuterne  ⁴     Benjamin Pariente  ⁵     Mathurin Fumery  ⁶     David Laharie  ⁷     Xavier Roblin  ⁸     Gilles Bommelaer  ⁸     Bruno Pereira  ⁸     Laurent Peyrin-Biroulet  ⁹     Lucine Vuitton  ^10    
1 CHU Estaing, Clermont-Ferrand, France
² HCL-Lyon Sud, Pierre Benite, France
³ University of Chicago Medicine, Chicago, United States
⁴ Hospital Archet 2, Nice, France
⁵ CHRU Lille, Lille, France
⁶ Amiens University Hospital, Amiens, France
⁷ CHU de Bordeaux Hopital Haut-Leveque, Pessac Cedex, France
⁸ University of St. Etienne, Saint Etienne, France
⁹ Nancy University Hospital Inserm U954, Vandoeuvre les Nancy, France
¹⁰ Besançon University Hospital, Besançon, France

Topic
IBD

Session
IBD: Clinical trials III

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)